Targeting SHP2 to reverse immune evasion and resistance to anti-PD-1 therapy in non-small cell lung cancer. - Chen, Shiwei; Wang, Dingguo; Xiong, Dian; Zhang, Lingxian; Li, Kunchao; Wang, Jing; Ma, Xiong; Hu, Xingchen; Zeng, Lei; Xu, Jianjun; Wu, Yongbing (Cell Communication & Signaling, 2025)